CanaQuest Medical Corp.
CANQF
$0.00
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 398.95% | 29.31% | |||
| Depreciation & Amortization | 138.46% | -73.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 305.17% | 213.66% | |||
| Operating Income | -305.17% | -213.66% | |||
| Income Before Tax | -777.95% | 16.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -777.95% | 16.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -777.95% | 16.73% | |||
| EBIT | -305.17% | -213.66% | |||
| EBITDA | -306.78% | -251.31% | |||
| EPS Basic | -637.25% | 19.05% | |||
| Normalized Basic EPS | -634.38% | 17.95% | |||
| EPS Diluted | -637.25% | 19.05% | |||
| Normalized Diluted EPS | -634.38% | 17.95% | |||
| Average Basic Shares Outstanding | 18.50% | 3.52% | |||
| Average Diluted Shares Outstanding | 18.50% | 3.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||